Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose febuxostat in elderly patients with chronic kidney disease and hyperuricemia
ChiCTR2200067196Phase 4Completed
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat in hyperuricemia (3 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Blood creatinine at month 3, Uric acid at month 3 and 1 more. Started Mar 2021; status: completed.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR2200067196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067196.